**
AstraZeneca is seeking a leader for their Early Assets Biomarker Pipeline role, focusing on diagnostics strategy and biomarker-based patient selection. The position requires a blend of scientific expertise and stakeholder engagement skills to enhance patient outcomes in oncology through innovative diagnostic solutions.
**
Job Summary
The role leads the diagnostics strategy for pipeline indications requiring biomarker-based patient selection to ensure scientific robustness and alignment with AstraZeneca's precision medicine goals.
Candidates will conduct diagnostic readiness assessments by identifying barriers such as assay standardization, reimbursement issues, and lab capacity across different regions.
AstraZeneca offers an environment where innovation thrives, allowing team members to transform cancer treatment through entrepreneurial thinking and collaboration.
Matching Summary
Match Score: 75
**
AstraZeneca is seeking a leader for their Early Assets Biomarker Pipeline role, focusing on diagnostics strategy and biomarker-based patient selection. The position requires a blend of scientific expertise and stakeholder engagement skills to enhance patient outcomes in oncology through innovative diagnostic solutions.
**
Skills & Requirements
Must-have
5+ years pharmaceutical industry experience
Biomarker strategy and CDx expertise
Oncology and precision medicine knowledge
Stakeholder management in diagnostics ecosystem
Regulatory and access framework understanding
Nice-to-have
PhD in Life Sciences preferred
Experience with launch or pre-launch activities
Strong cross-functional collaboration skills
Ability to synthesize complex data insights
Advanced English proficiency required
Key Requirements
Bachelor's degree in Life Sciences
Minimum 5 years in Diagnostics or Medical Affairs
Proven experience in biomarker strategy or companion diagnostics
Preferred PhD in Life Sciences with Oncology focus